Oxybutynin Chloride Extended-Release Tablets

Type of Posting: 
Revision Bulletin
Posting Date: 
30–June–2010
Official Date: 
01–Aug–2010
Expert Committee: 
Biopharmaceutics

In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Oxybutynin Chloride Extended-Release Tablets monograph.  The purpose for the revision is to include Dissolution Test 2 (inclusion of 15 mg tablets), Dissolution Test 3, and Dissolution Test 4.

The Oxybutynin Chloride Extended-Release Tablets Monograph Revision Bulletin supersedes the currently official Oxybutynin Chloride Extended-Release Tablets Monograph. The Revision Bulletin will be incorporated in USP 34–NF 29.

Should you have any questions, please contact Margareth Marques, Ph.D. (301-998-8106 or  mrm@usp.org).